Armata Pharmaceuticals (ARMP) Non-cash Items (2014 - 2026)

Armata Pharmaceuticals has disclosed Non-cash Items across 13 years of filings, most recently posting $2.9 million for Q1 2026.

• Non-cash Items for Q1 2026 came in at $2.9 million, up 21.06% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.9 million (up 21.06% YoY), and the FY2025 annual result was $2.3 million, up 57258.42% from the prior year.
• Non-cash Items came in at $2.9 million for Q1 2026 at Armata Pharmaceuticals, down from $15.0 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $15.0 million in Q4 2025 to a low of $1375.0 in Q1 2023.
• The 5-year median for Non-cash Items is $1.3 million (2022), against an average of $2.0 million.
• Across the five-year window, Non-cash Items sank 99.86% in 2023 and surged 376025.0% in 2025, its largest moves.
• Armata Pharmaceuticals' Non-cash Items stood at $1.4 million in 2022, then sank by 70.17% to $429000.0 in 2023, then slumped by 99.07% to $4000.0 in 2024, then soared by 376025.0% to $15.0 million in 2025, then sank by 80.59% to $2.9 million in 2026.
• The last three Non-cash Items figures came in at $2.9 million (Q1 2026), $15.0 million (Q4 2025), and $1.6 million (Q3 2025), per Business Quant data.